Dr. Larry Lynd has been appointed dean pro tem of the Faculty of Pharmaceutical Sciences, commencing August 1, 2023.
Dr. Lynd, professor and director of the Collaboration of Outcomes Research and Evaluation (CORE), currently also serves as associate dean, research in the Faculty. A pharmacist, epidemiologist and health outcomes researcher, he completed his PhD in the Department of Health Care and Epidemiology at UBC and a postdoctoral fellowship in health economics at McMaster University. His research focuses on the integration of epidemiologic and health economic analyses on health outcomes and includes the testing and treatment of rare diseases, multiple sclerosis, and respiratory disease. Further information on his research activities can be found here.
Dr. Lynd has a long-standing history with UBC Pharm Sci, joining in 1990 as a clinical faculty member and then becoming a full-time tenure track faculty member in 2004. He has contributed significantly to a number of committees nationally and provincially, including as chair of the Health Canada Special Advisory Committee on Non-prescription Drugs and the BC Ministry of Health Services Expensive Drugs for Rare Diseases Committee.
Dr. Michael Coughtrie will conclude his term as dean of the Faculty of Pharmaceutical Sciences on July 31, 2023. During his term, Dr. Coughtrie has overseen an unprecedented expansion of the Faculty which has led to major successes in research, education & training, and innovation in pharmacy practice. Faculty highlights include two multi-year strategic plans; four new academic programs and innovations in graduate training; growth and advancement of the research enterprise; and innovations in clinical pharmacy practice that have made a real difference to health outcomes. Additionally, Dr. Coughtrie has been instrumental in furthering the Faculty’s efforts in the areas of equity, diversity, inclusion, and Indigeneity, where the Faculty is now an acknowledged leader among peer institutions in the pharmaceutical sciences.